Transcatheter Aortic-Valve Replacement for Inoperable Severe Aortic Stenosis
Raj Makkar(Cedars-Sinai Medical Center), Martin B. Leon(Columbia University Irving Medical Center), William N. Anderson(Edwards Lifesciences (United States)), Vasilis Babaliaros(Valve (United States)), Susheel Kodali(Columbia University Irving Medical Center), Stuart Pocock(London School of Hygiene & Tropical Medicine), Lars G. Svensson(Cleveland Clinic), Hasan Jilaihawi(NYU Langone Health), Robert J. Siegel(Cedars-Sinai Smidt Heart Institute), John G. Webb(St. Paul's Hospital), Todd Dewey(Medical City Dallas Hospital), Pamela S. Douglas(Duke University), Bruce Bowers, Jeffrey W. Moses(Good Samaritan University Hospital), Jodi J. Akin(Edwards Lifesciences (United States)), Howard C. Herrmann(University of Pennsylvania), Gregory P. Fontana(HCA Healthcare), Mathew Williams(Mount Sinai Health System), Samir Kapadia(Cleveland Clinic), David L. Brown(Baylor Scott & White Health), Murat Tuzcu, Craig R. Smith(University of Arizona), Vinod H. Thourani(Valve (United States)), Augusto D. Pichard(MedStar Washington Hospital Center), Joseph E. Bavaria(University of Pennsylvania)
Cited by 1,346
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k